[1] RINGELHAN M,PFISTER D,O'CONNOR T,et al.The immunology of hepatocellular carcinoma[J].Nature Immunol,2018,19(3):222.
[2] ABOU-ALFA GK,MEYER T,CHENG AL,et al.Cabozantinib in patients with advanced and progressing hepatocellular carcinoma[J].N Engl J Med,2018,379(1):54. doi: 10.1056/NEJMoa1717002
[3] European Association for the Study of the Liver.EASL Clinical Practice Guidelines:Management of hepatocellular carcinoma[J].J Hepatol,2018,69(1):182.
[4] PARDOLL DM.The blockade of immune checkpoints in cancer immunotherapy[J].Nat Rev Cancer,2012,12(5):252.
[5] SHEN JK,COTE GM,CHOY E,et al.Programmed cell death ligand 1 expression in osteosarcoma[J].Cancer Immunol Res,2014,2(7):690. doi: 10.1158/2326-6066.CIR-13-0224
[6] SOLIMAN H,KHALIL F.PD-L1 expression is increased in a subset of basal type breast cancer cells[J].PLoS One,2014,9(2):e88557.
[7] CHEN YB,MU CY.Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer:A 5-year-follow-up study[J].Tumori,2012,98(6):751. doi: 10.1177/030089161209800612
[8] DROESER RA,HIRT C,VIEHL CT,et al.Clinical impact of programmed cell death ligand 1 expression in colorectal cancer[J].Eur J Cancer,2013,49(9):2233. doi: 10.1016/j.ejca.2013.02.015
[9] BERGHOFF AS,RICKEN G,WIDHALM G,et al.PD1(CD279) and PD-L1(CD274,B7H1) expression in primary central nervous system lymphomas (PCNSL)[J].Clin Neuropathol,2014,33(1):42. doi: 10.5414/NP300698
[10] BIGELOW E,BEVER KM,XU H,et al.Immunohistochemical staining of B7-H1(PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue[J].J Vis Exp,2013,1(3):71.
[11] CURIEL TJ,WEI S,DONG H,et al.Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity[J].Nature Med,2003,9(5):562. doi: 10.1038/nm863
[12] STROME SE,DONG H,TAMURA H,et al.B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma[J].Cancer Res,2003,63(19):6501.
[13] 苏纯洁,何前进,毛伟明,等.肝癌组织中PD-L1和HIF-1α的相关性研究[J].中国现代普通外科进展,2019,22(1):22.
[14] 蒋涛,付立业,李妍.RNAi沉默肺腺癌A549细胞系PD-L1基因表达对其增殖和凋亡的影响[J].现代肿瘤医学,2015,23(2):177. doi: 10.3969/j.issn.1672-4992.2015.02.09
[15] 周婷,严玉荣,赵晨辰,等.PD-L1蛋白过表达对HeLa细胞迁移能力的影响[J].生物技术,2017,27(6):557.
[16] SWAIKA A,HAMMOND WA.Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy[J].Mol Immunol,2015,67(2 Pt A):4. doi: 10.1016/j.molimm.2015.02.009